In pancreatic cancer, ferroptotic cells release KRAS G12D, which polarizes macrophages to an M2 phenotype through STAT3 signaling, promoting immune suppression and tumor progression [698, 699, 700, 701]. The gene discussed is KRAS; the disease is pancreatic neoplasm.